The Future of TAVR: 3-Year SMART Trial Results

  • Published:  18 June 2026
  • Likes: 

    Heart Icon

    1

Up Next
  • episode_image
    2m 46s
    Part 1 | Session 1 Welcome & Introduction
    Howard C Herrmann, Leonardo Guimarães, Pablo Lamelas, Walid Ben Ali, Alejandro Alcocer
  • episode_image
    2m 45s
    Part 2 | Session 1 Welcome & Introduction
    Howard C Herrmann, Zarina Sharalaya, Matthew Summers, Kelly C. Epps Anderson, Craig Basman , Leonardo Guimarães, Alejandro Alcocer, Pablo Lamelas, Walid Ben Ali

The Future of TAVR: 3-Year SMART Trial Results

  • Published:  18 June 2026
  • Likes: 

    Heart Icon

    1

Average (ratings)
No ratings
Your rating
Overview

The Future of TAVR: 3-Year SMART Trial Results webinar series explores the key outcomes of the SMART Trial and what they reveal about improving care for patients undergoing transcatheter valve intervention.

The series focuses on how trial findings inform everyday clinical decisions, with particular attention to bioprosthetic valve dysfunction, prosthesis–patient mismatch and thrombosis. Special consideration is given to small annuli patients, including those with an annular area below 430 mm², and to women, where anatomy and haemodynamics can significantly influence outcomes. The discussion connects evidence to practice, highlighting how structured pre-procedural planning, imaging and patient selection can optimise results.

This video series is supported by

Key Learning Objectives

  • Outline definitions and types of BVD, preventative strategies, and implications.
  • Translate trial results into real-world clinical practice.
  • Understand how pre-case planning, imaging, and tools can support patient selection.
  • Identify indicators of low-flow, low-gradient severe aortic stenosis.

Target Audience

  • Interventional Cardiologists
  • Structural Heart Intervention Specialist
  • Cardiac Imaging Specialists
  • Cardiothoracic surgeon

More from this programme

Faculty Biographies

Ashok Seth

Chairman, Chief Cardiologist

View full profile
Howard C Herrmann

Howard C Herrmann

Director, Cardiac Catheterization Laboratories

Howard C Herrmann, MD, is a Professor of Medicine at the University of Pennsylvania School of Medicine and Director of Interventional Cardiology and the Cardiac Catheterization Laboratories at the Hospital of the University of Pennsylvania, Philadelphia. He has authored or co-authored more than 200 articles on numerous topics in interventional cardiology. His research focuses on the clinical investigation of new therapies for valvular and structural heart disease. He is Past President of the Pennsylvania Chapter of the American College of Cardiology (ACC) and serves on numerous national committees and Editorial Boards. Dr Herrmann earned his AB at Harvard College and his MD at Harvard Medical School, and completed his training at Massachusetts General Hospital.

View full profile
Radoslaw Parma

Radoslaw Parma

MD. PhD.

Medical University of Silesia in Katowice | SUM | Division of Cardiology and Structural Heart Disease 

 

 

View full profile

Comments

You must be to comment. If you are not registered, you can register here.